Nurse Practitioner, Family · Menasha, WI
NPI
1669952297
Since 2018
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
1550 Midway Pl
Menasha, WI, 54952
Phone (920) 727-8030
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
465 services
Medicare patients, 2024
135
Average age 69
Drug cost, 2024
$1.7M
3,471 prescriptions
Company payments, 2025
$1,038
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Megan E Gebhart was code 99214 (office e&m - established), 215 times for 122 patients. In total Megan E Gebhart billed 465 services in 11 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 215 | 122 | $72.58 | $16K |
| 83036 Blood Count | Office | 146 | 81 | $9.52 | $1,390 |
| 36415 Venipuncture Blood Collection | Office | 59 | 40 | $8.65 | $510 |
| 95251 Test - Miscellaneous | Office | 25 | 18 | $20.53 | $513 |
By year: 2022 $21K for 485 services; 2023 $19K for 439 services; 2024 $19K for 465 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 146 | 81 | $9.52 | $1,390 |
| 36415 Venipuncture Blood Collection | 59 | 40 | $8.65 | $510 |
Medicare prescription drug claims, 2024
In 2024, the drug Megan E Gebhart prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 268 prescriptions and refills. In total Megan E Gebhart wrote 3,471 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 268 | 463 | 65 | $269K |
| Ozempic Semaglutide | 267 | 388 | 58 | $361K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 246 | 398 | 84 | $43K |
| Levothyroxine Sodium Generic | 235 | 468 | 50 | $2,945 |
| Trulicity Dulaglutide | 151 | 210 | 29 | $204K |
| Methimazole Generic | 144 | 245 | 26 | $2,181 |
| Metformin Hcl Er Metformin Hcl | 140 | 318 | 41 | $1,815 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 140 | 226 | 26 | $103K |
| Metformin Hcl Generic | 126 | 293 | 46 | $1,385 |
| Novolog Flexpen Insulin Aspart | 88 | 130 | 31 | $21K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 83 | 172 | 31 | $8,017 |
| Humalog Kwikpen U-100 Insulin Lispro | 77 | 117 | 23 | $28K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 77 | 159 | 23 | $84K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 68 | 79 | 21 | $18K |
| Glipizide Er Glipizide | 63 | 110 | 11 | $779 |
Brand drugs: 2,353 claims; generic drugs: 738 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Megan E Gebhart $1,038 ($1,038 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbott Laboratories with $813.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.